In 2022, there were up to 1.2 million people with HIV (PWH) and 37,981 new cases of HIV in the United States alone. 1 While ...

The BRAAVE2020 study investigated the efficacy of switching Black Americans living with HIV to a B/F/TAF single-pill regimen.

The study from Tulane University found that those living in once-redlined neighborhoods see 15% longer delays in achieving successful viral suppression of HIV compared to those in non-redlined areas.

Specific subtypes and transmission clusters for HIV could require targeted interventions to control spread of HIV that is ...

Continuing their journey to develop a vaccine for HIV, Oregon Health & Science University researchers have identified a gene ...

Dolutegravir is an HIV integrase strand transfer inhibitor (INSTI) that does not require pharmacokinetic boosting, has a long half-life allowing for once-daily dosing in treatment-naive patients ...

“We are talking about sex and drugs—two topics that people call taboo,” said Brigitte Quenum, UNAIDS Regional Team Lead for ...

and these new data continue to reinforce the efficacy and safety of Dovato, a two-drug regimen. “The findings from the DOLCE ...

"Our study provides new insights into the numbers and characteristics ... focuses on proactive use of effective antiretroviral therapy (ART) for HIV, as well as pre- and post-exposure prophylaxis ...

A new study found that iron supplements are safe for children with HIV in Uganda, as they improve hemoglobin levels without ...